Applied DNA Sciences 8-K Report: Key Developments for Investors - Feb 2025

Based on the provided excerpt from the financial report, here are the key pieces of information and insights:

Entity Information:

Company Name: Applied DNA Sciences, Inc.
CIK: 0000744452
SIC Code: 001-36745
Tax ID: 59-2262718
Address: 50 Health Sciences Drive, Stony Brook, NY 11790
Phone Number: 631-240-8800
Stock Symbol: APDN
Exchange: NASDAQ

Filing Details:

Form Type: 8-K (This form is used to report major events that shareholders should know about.)
Filing Date: February 13, 2025

Financial Information:

Common Stock Par Value: $0.001
Unit of Measure: The financial data is reported in USD (United States Dollars) and shares.

Context Information:

Reporting Date: The report is as of February 13, 2025.
Period: Both the start and end date of the reporting period is February 13, 2025.

Insights:

The report indicates a specific event or development that may be significant for shareholders, as it is filed under Form 8-K.
The company's minimal par value of $0.001 for its common stock suggests it may be in the early stages of development or operating at a low capitalization level.
The company's address in Stony Brook, NY, suggests it may be strategically positioned for research and development in the health sciences sector, given its name and associated address.
The consistent reporting format (XBRL) indicates compliance with SEC electronic reporting requirements, enhancing the accessibility and analysis of the financial data.

Overall, the document reflects a formal disclosure by Applied DNA Sciences, Inc., which may be crucial for investors and analysts monitoring the health sciences sector. Further details from the full 8-K filing would be necessary to assess the specific events or changes reported that could impact the company's financial standing or operations.